Services

We are here to help in anything you need. Please use our online system or send an email to .

Photocatalysis Reaction Technology Platform

Photocatalysis reaction technology involves the use of light to drive chemical reactions, often with the help of a catalyst. This technology has gained increasing interest in recent years, particularly in the field of small molecule drug discovery and development. Photocatalysis reaction technology can enable the generation of complex molecular structures in a more efficient and environmentally friendly manner compared to traditional synthetic methods. In addition, by activating photoactive catalysts under light irradiation, photocatalysis enables previously inaccessible chemical transformations, paving the way for the rapid generation of novel drug candidates.

Our company provides innovative photocatalytic reaction technology platforms for discovering new compounds, optimizing chemical reactions, and synthesizing drugs. By utilizing specially designed catalysts that can be activated by light, we are able to accelerate chemical reactions with precision and efficiency, thereby synthesizing high-value molecular building blocks and drug intermediates and advance drug discovery. At present, our photocatalytic reaction technology platform has achieved the production of drug intermediates from kilograms to hundreds of kilograms.

Our Photocatalysis Reaction Technology Platform

Through our photocatalytic reaction technology platform, we offer a range of innovative services. Our team of experienced chemists and researchers are skilled in designing and executing photocatalysis reactions to facilitate faster, more sustainable, and efficient drug discovery processes. The services we provide mainly include the following aspects.

Development of novel drugs and drug delivery systems. By utilizing our photocatalysis reaction technology platform, we can assist in the development of new drugs and drug delivery systems that offer improved efficacy, stability, and targeted delivery.
Process optimization and scale-up. Our team of experts can optimize reaction conditions and scale-up manufacturing processes to ensure efficient and cost-effective production of drug intermediates and APIs using photocatalysis technology.
Custom synthesis of drug intermediates, building blocks and active pharmaceutical ingredients (APIs). We can provide customized synthesis services for pharmaceutical intermediates and APIs using our photocatalysis technology, allowing for the creation of complex molecules in a efficient and cost-effective manner.

Platform Equipment

Our photocatalytic reaction technology platform utilizes a range of advanced equipment to produce valuable molecular building blocks, drug intermediates and APIs with high efficiency and selectivity. Our equipment includes but is not limited to the following:

Parallel photochemical reactor
Fixed bed photoreactor
High-throughput photoreactor
Gas chromatograph
High performance liquid chromatograph
Glove box
High pressure reactor

Platform Advantages

Our photocatalytic reaction technology platform has the ability to independently design new photocatalysts (photosensitive metal complexes), and also has the ability to conduct general photocatalytic organic chemical reactions and mechanism research.

Our photocatalytic reaction technology platform has the ability to efficiently construct bridged rings, fused rings and polycyclic compounds.

Our photocatalytic reaction technology platform has a certain technical foundation for the construction of C-X (C-N, C-P, C-O, etc.) bonds, and will surely provide more and better services for drug research and development.

Our photocatalytic reaction technology platform offers unparalleled precision and selectivity in drug synthesis, leading to higher yields and purer products. By harnessing the power of photocatalytic reactions, we can achieve chemical transformations that are not feasible using traditional methods, opening up new possibilities for drug design and optimization.

It should be noted that our service is only used for research, not for clinical use.

Inquiry